Easy Light Glycometer (ELG) is the first product designed specifically for patients with diabetes type 1 and 2, and is in the investigative phase to evaluate and measure both A1C and glucose without the pain and inconvenience of a finger stick or inserted device.
Who and where:
The trial will be conducted in a clinical setting in Fayetteville, AR with a highly qualified team of medical professionals that are complying with all FDA investigational device study guidelines. If you qualify through the initial phone screening process the Clinical Research Project Manager, Tonya Xaysanasy, MA, will contact you to verify your information, schedule your start date and let you know where to go, if accepted into the study.
Timing:
The trial starts in the fall of 2018 and will be running for 12 months. If you are accepted into the trial, your start date will be provided to you at that time with instructions on how to participate.
Level of commitment:
You will participate over a two-week period. You will need to spend 2 hours per visit and only make two visits within this two week period. There will be 4 blood draws for a complete blood testing and you must be fasting for 6 hours prior to each (blood draw) visit.
Compensation:
$120.00 for complete study participation